Skip to content

NPF Hosts First Biotech Innovation Showcase

The National Pancreas Foundation hosted its first Biotech Innovation Showcase at the annual American Pancreatic Association meeting. This Showcase highlighted 7 innovative companies in the pancreas space who are looking for partnerships to continue to grow and advance their companies and to help those fighting pancreatic disease. To review the presentations, please click here  

The National Pancreas Foundation Announces the Designation of 28 Centers for Pancreatic Cancer

The National Pancreas Foundation Announces the Designation of Twenty-Eight NPF Centers for the Treatment and Care of Pancreatic Cancer BETHESDA, MD – September 14, 2016 – The National Pancreas Foundation (NPF), a nonprofit organization that provides hope for those suffering from pancreatitis and pancreatic cancer, announces the designation of twenty-eight additional National Pancreas Foundation Centers for… Read More »The National Pancreas Foundation Announces the Designation of 28 Centers for Pancreatic Cancer

2016 Research Grant Recipients

The National Pancreas Foundation Announces 2016 Research Grant Recipients NPF Awards 300,000 Dollars to Research Bethesda, MD – April 25, 2016 – The National Pancreas Foundation (NPF), a nonprofit organization dedicated to funding cutting edge research, advocating for new and better therapies, and providing support and education for those impacted by pancreatic disease, announced today that… Read More »2016 Research Grant Recipients

Designation of Seven Additional NPF Centers

The National Pancreas Foundation Announces the Designation of Seven Additional NPF Centers for the Care and Treatment of Pancreatitis BETHESDA, MD – February 19, 2016 – The National Pancreas Foundation (NPF), a nonprofit organization that provides hope for those suffering from pancreatitis and pancreatic cancer, announces the designation of seven additional National Pancreas Foundation Centers.… Read More »Designation of Seven Additional NPF Centers

FDA approves new treatment for advanced pancreatic cancer

The U.S. Food and Drug Administration today approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to treat patients with advanced (metastatic) pancreatic cancer who have been previously treated with gemcitabine-based chemotherapy. According to the National Cancer Institute, there will be 48,960 new cases of pancreatic cancer diagnosed in the U.S. in 2015,… Read More »FDA approves new treatment for advanced pancreatic cancer

Announcing the Designation of 30 NPF Centers

The National Pancreas Foundation Announces the Designation of 30 NPF Centers for the Care and Treatment of Pancreatitis BETHESDA, MD – Sept. 1, 2015 – The National Pancreas Foundation (NPF), a nonprofit organization that provides hope for those suffering from pancreatitis and pancreatic cancer, announces the designation of 30 National Pancreas Foundation Centers. NPF Centers are… Read More »Announcing the Designation of 30 NPF Centers